Honest Company Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Honest Company Inc trades at $5.18 (market cap $558.95M), while Regeneron Pharmaceuticals Inc trades at $796.06 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 146.8× Honest Company Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Honest Company Inc pays none. Which is the better fit depends on your goals.
| HNST | REGN | |
|---|---|---|
Market Cap | $558.95M | $82.06B |
Sector | Consumer Staples | Health |
52-Week High | $5.46 | $812.27 |
52-Week Low | $2.10 | $555.51 |
Enterprise Value | $462.56M | $76.77B |
Dividend Yield | — | 0.47% |
Signals from Pluang's Aura AI — not financial advice
HNST trades at $5.23, down 4.21% today, with a bullish technical signal from moving averages but overbought RSI readings. The company shows mixed fundamentals with Q2 2026 EPS beating estimates at $0.04 versus $0.00926 expected, though revenue declined to $342M in 2026 with a net loss of $12M. Operating cash flow improved to $57M in 2026, and strategic exits are showing progress according to recent company updates.
The outlook remains cautious due to persistent net losses and margin pressure, offset by improving cash flow and recent earnings beats. Key risks include sustained profitability challenges and competitive pressures in personal care markets, while analyst sentiment is mixed with 30% buy ratings amid ongoing turnaround efforts.
Regeneron Pharmaceuticals (REGN) trades at $808.05, up 3.02% today, with strong technical momentum and bullish moving averages. The company shows robust fundamentals: Q2 2026 EPS of $14.29 beat expectations by over 40%, revenue grew to $14.34B in 2025, and profit margins exceed 27%. However, RSI levels above 95 indicate overbought conditions, and the stock faces headwinds from multiple class-action lawsuits related to clinical trial disclosures.
Outlook remains positive due to earnings beats and product strength in Eylea HD and Dupixent, but legal overhangs and high valuation multiples pose near-term risks. Analysts maintain a Buy consensus with a $756.93 price target, suggesting cautious optimism amid legal scrutiny.
Trailing returns across standard periods
The Honest Co Inc is a consumer products company. It offers eco-friendly diapers and a natural line of bath, skincare, home cleaning, and organic nutritional supplement products and other products.
Read more on HNST →Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →